Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN115093315B reveals a novel inorganic salt-catalyzed route for 2-benzylidene-3-cyclohexenone, offering cost-effective and scalable pharmaceutical intermediate manufacturing.
Patent CN116041393B reveals a novel N-N axis chiral bis-indole phosphine ligand synthesis offering superior stereoselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN114920707B reveals a novel iodine-catalyzed route using DMF as a carbon source for high-purity 1,2,4-triazole derivatives, offering significant cost reduction in API manufacturing.
Patent CN115385895A reveals a novel Pd-catalyzed route for 2-trifluoromethyl indoles, offering cost-effective manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN112410807B reveals a metal-free electrocatalytic route for tetra-substituted sulfonated vinyl ethers, offering green synthesis and high purity for pharmaceutical intermediates.
Patent CN112047842A details a green Pd-catalyzed method for 1,4-diene synthesis using allylic alcohols, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed method for benzopyran thioesters. Reduces toxicity, improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108610304B reveals a novel Pd-catalyzed C-H activation route for diarylsultams, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN110724164B details novel pyridine-substituted spiro ligands enabling high TON hydrogenation. Ideal for API intermediates.
Novel silver-mediated method for high-purity isoquinoline intermediates. Reduces synthetic steps, improves yield, and ensures supply chain stability for pharma manufacturing.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route to 2-trifluoromethyl quinazolinones, offering reliable supply chain solutions for API manufacturing.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Cost-effective, scalable route for pharma intermediates.
Novel FeCl3-catalyzed route for quinazolinones offers high yields and cost efficiency for pharmaceutical intermediate manufacturing and supply chain stability.
Patent CN101717408B introduces a bis-phosphorus ylide ligand enabling high-yield alpha-arylation. This breakthrough offers significant cost reduction in API manufacturing and robust supply chain reliability.
Patented Cu-catalyzed method for diynes reduces metal waste and enables mild conditions. Ideal for API intermediates. Cost-effective scale-up for global supply chains.
Patent CN115353511A details a novel multi-component Pd-catalyzed method for synthesizing carbonyl-bridged biheterocycles, offering safer conditions and cost reduction in API manufacturing.
Patent CN113735826B reveals a novel Pd-catalyzed carbonylation route for high-purity quinolone intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical applications.
Novel metal-free route for trifluoromethyl 1,2,4-triazines. High yields, mild conditions, scalable process for API intermediates.
Patent CN115304477B reveals oxidative esterification breakthrough enabling high-purity aromatic esters with simplified workflow and substantial supply chain cost reduction advantages.
Patent CN113666862A reveals a nickel-catalyzed asymmetric nitration method for chiral 3-nitroindoles, offering high enantioselectivity and cost-effective manufacturing solutions.